Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 82 of 99

  1. TAK-781

    Takeda

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  2. TAK-788

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  3. TAK-792 30 mg

    Takeda

    Healthy Male Adults Participants

    phase 1 small molecule completed

    1 trial

  4. TAK-828

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    1 trial

  5. TAK-828

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  6. TAK-831

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  7. TAK-831

    NEUROCRINE BIOSCIENCES INC

    Healthy

    phase 1 small molecule completed

    1 trial

  8. TAK-831 Oral Suspension

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia, Cerebellar Ataxia

    phase 1 small molecule terminated

    1 trial

  9. TAK-831 Oral Tablet

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. TAK-831 T2

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. TAK-831 Tablet T2

    NEUROCRINE BIOSCIENCES INC

    Healthy

    phase 1 small molecule completed

    1 trial

  12. TAK-861-1012

    Takeda

    Narcolepsy with Cataplexy (Narcolepsy Type 1)

    phase 1 small molecule active

    1 trial

  13. TAK-875 and Glimepiride

    Takeda

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  14. TAK-881

    Takeda

    Healthy Volunteers

    phase 1 mab completed

    3 trials

  15. TAK-906

    Takeda

    Japanese Healthy Adult Male Participants

    phase 1 small molecule completed

    1 trial

  16. TAK-906

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  17. TAK-906 Maleate

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  18. TAK-906 Oral Capsule

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. TAK-915

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. TAK-915 suspension

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  21. TAK-925

    Takeda

    Healthy Participants and Patients With Narcolepsy

    phase 1 small molecule completed

    1 trial

  22. TAK-925

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. TAK-925

    Takeda

    Idiopathic Hypersomnia

    phase 1 small molecule completed

    1 trial

  24. TAK-925

    Takeda

    Obstructive Sleep Apnea

    phase 1 small molecule completed

    1 trial

  25. TAK-925

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  26. TAK-931

    Takeda

    Nonhematologic Neoplasms, Advanced

    phase 1 small molecule completed

    1 trial

  27. TAK-931 PIC

    Takeda

    Neoplasms, Advanced Solid

    phase 1 small molecule completed

    1 trial

  28. TAK-935

    Takeda

    Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents

    phase 1 small molecule completed

    1 trial

  29. TAK-935

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. TAK-935

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  31. TAK-935 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  32. TAK-935 Tablets

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  33. TAK-951

    Takeda

    Nausea and Vomitting

    phase 1 small molecule terminated

    1 trial

  34. TAK-951

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  35. TAK-951

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  36. TAK-951 Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  37. TAK-954

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  38. TAK-954

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  39. TAK-954

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  40. TAK-954

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  41. TAK-981

    Takeda

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  42. TAK-988

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  43. TAK-994

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    2 trials

  44. TAK-994

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  45. TAK-994 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  46. TAKC-02

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  47. TALEN

    The First People's Hospital of Lianyungang

    Human Papillomavirus-Related Malignant Neoplasm

    phase 1 mab active

    1 trial

  48. TAMSU-12-24

    Lacuna Pharma Pty Ltd

    Benign prostatic hyperplasia (BPH)

    phase 1 other active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.